Septo-optic dysplasia

European Journal of Human Genetics

Volumn 18, Issue 4, 2010, Pages 393-397

  Webb, Emma A ^a   Dattani, Mehul T ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Optic nerve hypoplasia; Pituitary; Septum pellucidum

Indexed keywords

TRANSCRIPTION FACTOR HESX1; TRANSCRIPTION FACTOR SOX2;

ANAMNESIS; BRAIN MALFORMATION; CLINICAL FEATURE; ENDOCRINE DISEASE; ENDOCRINE FUNCTION TEST; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC POLYMORPHISM; GROWTH RETARDATION; HUMAN; MOLECULAR GENETICS; MUTATIONAL ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE HYPOPLASIA; PATHOGENESIS; PATIENT MONITORING; PHENOTYPIC VARIATION; PRIORITY JOURNAL; REVIEW; SEPTOOPTIC DYSPLASIA;

HUMANS; SEPTO-OPTIC DYSPLASIA;

EID: 77949656830     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2009.125     Document Type: Review

References (40)

1. Patel L, McNally RJ, Harrison E et al: Geographical distribution of optic nerve hypoplasia and septo-optic dysplasia in Northwest England. J Pediatr 2006; 148: 85-88.
2. Lippe B, Kaplan SA, LaFranchi S: Septo-optic dysplasia and maternal age. Lancet 1979; 2: 92-93.
3. Dattani MT, Martinez-Barbera JP, Thomas PQ et al: Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet 1998; 19: 125-133.
4. Kelberman D, Rizzoti K, Avilion A et al: Mutations within Sox2/SOX2 are associated with abnormalities in the hypothalamo-pituitary-gonadal axis in mice and humans. J Clin Invest 2006; 116: 2442-2455.
5. Kelberman D, de Castro SC, Huang S et al: SOX2 plays a critical role in the pituitary, forebrain and eye during human embryonic development. J Clin Endocrinol Metab 2008; 93: 1865-1873.
6. Sato N, Kamachi Y, Kondoh H et al: Hypogonadotropic hypogonadism in an adult female with a heterozygous hypomorphic mutation of SOX2. Eur J Endocrinol 2007; 156: 167-171.
7. Kelberman D, Dattani MT: Septo-optic dysplasia-novel insights into the aetiology. Horm Res 2008; 69: 257-265.
8. McNay DE, Turton JP, Kelberman D et al: HESX1 mutations are an uncommon cause of septooptic dysplasia and hypopituitarism. J Clin Endocrinol Metab 2007; 92: 691-697.
9. Kelberman D, Dattani MT: Genetics of septo-optic dysplasia. Pituitary 2007; 10: 393-407.
10. Elster AB, McAnarney ER: Maternal age re septo-optic dysplasia. J Pediatr 1979; 94: 162-163.
11. Reeves DL: Congenital absence of the septum pellucidum. Bull Johns Hopkins Hosp 1941; 69: 61-71.
12. De Morsier G: Studies on malformation of cranio-encephalic sutures. III. Agenesis of the septum lucidum with malformation of the optic tract. Schweiz Arch Neurol Psychiatr 1956; 77: 267-292.
13. Hoyt WF, Kaplan SL, Grumbach MM et al: Septo-optic dysplasia and pituitary dwarfism. Lancet 1970; 1: 893-894.
14. Morishima A, Aranoff GS: Syndrome of septo-optic-pituitary dysplasia: the clinical spectrum. Brain Dev 1986; 8: 233-239.
15. Hellstrom A, Aronsson M, Axelson C et al: Children with septo-optic dysplasia-how to improve and sharpen the diagnosis. Horm Res 2000; 53 (Suppl1): 19-25.
16. Polizzi A, Pavone P, Iannetti P et al: Septo-optic dysplasia complex: a heterogeneous malformation syndrome. Pediatr Neurol 2006; 34: 66-71.
17. Barkovich AJ, Fram EK, Norman D: Septo-optic dysplasia: MR imaging. Radiology 1989; 171: 189-192.
18. Haddad NG, Eugster EA: Hypopituitarism and neurodevelopmental abnormalities in relation to central nervous system structural defects in children with optic nerve hypoplasia. J Pediatr Endocrinol Metab 2005; 18: 853-858.
19. Garcia ML, Ty EB, Taban M et al: Systemic and ocular findings in 100 patients with optic nerve hypoplasia. J Child Neurol 2006; 21: 949-956.
20. Rivkees SA: Arrhythmicity in a child with septo-optic dysplasia and establishment of sleep-wake cyclicity with melatonin. J Pediatr 2001; 139: 463-465.
21. Mehta A, Hindmarsh PC, Mehta H et al: Congenital hypopituitarism: clinical, molecular and neuroradiological correlates. Clin Endocrinol, e-pub ahead of print, 6 March 2009.
22. Thomas PQ, Dattani MT, Brickman JM et al: Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia. Hum Mol Genet 2001; 10: 39-45.
23. Cohen RN, Cohen LE, Botero D et al: Enhanced repression by HESX1 as a cause of hypopituitarism and septooptic dysplasia. J Clin Endocrinol Metab 2003; 88: 4832-4839.
24. Alatzoglou KS, Kelberman D, Dattani MT: The role of SOX proteins in normal pituitary development. J Endocrinol 2009; 200: 245-258.
25. Hagstrom SA, Pauer GJT, Reid J et al: SOX2 mutation causes anophthalmia, hearing loss, and brain anomalies. Am J Med Genet A 2005; 138A: 95-98.
26. Riedl S, Vosahlo J, Battelino T et al: Refining clinical phenotypes in septo-optic dysplasia based on MRI findings. Eur J Pediatr 2008; 167: 1269-1276.
27. Lubinsky MS: Hypothesis: septo-optic dysplasia is a vascular disruption sequence. Am J Med Genet 1997; 69: 235-236.
28. Stevens CA, Dobyns WB: Septo-optic dysplasia and amniotic bands: further evidence for a vascular pathogenesis. Am J Med Genet A 2004; 125A: 12-16.
29. Carvalho LR, Woods KS, Mendonca BB et al: A homozygous mutation in HESX1 is associated with evolving hypopituitarism due to impaired repressor- corepressor interaction. J Clin Invest 2003; 112: 1192-1201.
30. Tajima T, Hattorri T, Nakajima T et al: Sporadic heterozygous frameshift mutation of HESX1 causing pituitary and optic nerve hypoplasia and combined pituitary hormone deficiency in a Japanese patient. J Clin Endocrinol Metab 2003; 88: 45-50.
31. Coya R, Vela A, Perez de Nanclares G et al: Panhypopituitarism: genetic versus acquired etiological factors. J Pediatr Endocrinol Metab 2007; 20: 27-36.
32. Sobrier ML, Maghnie M, Vie-Luton MP et al: Novel HESX1 mutations associated with a life-threatening neonatal phenotype, pituitary aplasia, but normally located posterior pituitary and no optic nerve abnormalities. J Clin Endocrinol Metab 2006; 91: 4528-4536.
33. Sobrier ML, Netchine I, Heinrichs C et al: Alu-element insertion in the homeodomain of HESX1 and aplasia of the anterior pituitary. Hum Mutat 2005; 25: 503.
34. Zenteno JC, Gascon-Guzman G, Tovilla-Canales JL: Bilateral anophthalmia and brain malformations caused by a 20-bp deletion in the SOX2 gene. Clin Genet 2005; 68: 564-566.
35. Williamson KA, Hever AM, Rainger J et al: Mutations in SOX2 cause anophthalmia-esophageal-genital (AEG) syndrome. Hum Mol Genet 2006; 15: 1413-1422.
36. Bakrania P, Robinson DO, Bunyan DJ et al: SOX2 anophthalmia syndrome: 12 new cases demonstrating broader phenotype and high frequency of large gene deletions. Br J Ophthalmol 2007; 91: 1471-1476.
37. Andoniadou CL, Signore M, Sajedi E et al: Lack of the murine homeobox gene Hesx1 leads to a posterior transformation of the anterior forebrain. Development 2007; 134: 1499-1508.
38. Martinez-Barbera JP, Rodriguez TA, Beddington RS: The homeobox gene Hesx1 is required in the anterior neural ectoderm for normal forebrain formation. Dev Biol 2000; 223: 422-430.
39. Martinez-Barbera JP, Beddington RS: Getting your head around Hex and Hesx1: forebrain formation in mouse. Int J Dev Biol 2001; 45: 327-336.
40. Sajedi E, Gaston-Massuet C, Signore M et al: Analysis of mouse models carrying the I26T and R160C substitutions in the transcriptional repressor HESX1 as models for septo-optic dysplasia and hypopituitarism. Dis Model Mech 2008; 1: 241-254.